Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about PURETECH HEALTH PLC
09/20 PURETECH HEALTH : Notes US Patent Issuance Broadly Covering Methods of Assessing..
09/20 PURETECH HEALTH : Notes U.S. Patent Issuance Broadly Covering Methods of Assessi..
08/29 PURETECH HEALTH : Exclusively Licenses Glyph Technology from Monash University t..
08/25PURETECH HEALTH PLC : half-yearly earnings release
08/15 PURETECH HEALTH : Notice of Half-Yearly Results
07/13 PURETECH HEALTH : Presents Data Supporting Treatment Approach for Interstitial C..
07/12 PURETECH HEALTH : Gelesis Announces Last Patient Visit in the Pivotal Gelesis100..
07/12 PURETECH HEALTH : Gelesis Announces Last Patient Out in the Pivotal Gelesis100 W..
06/28 PURETECH HEALTH : Akili Appoints Former Cubist CEO, Rob Perez, as Executive Chai..
06/28 PURETECH HEALTH : Former Cubist CEO, DreamWorks Interactive CEO, and Google Chie..
05/30 PURETECH HEALTH : Vedanta Biosciences Granted U.S. Patent Broadly Covering Metho..
05/30 VEDANTA BIOSCIENCES : Granted U.S. Patent Broadly Covering Methods of Treatment ..
05/25 PURETECH HEALTH : to Present at Jefferies 2017 Global Healthcare Conference
05/19 PURETECH HEALTH : Karuna to Present Tolerability Proof-of-Concept Data for KarXT..
05/19 KARUNA PHARMACEUTICALS : to Present KarXT Tolerability Proof-of-Concept Data for..
More most relevant news
All news about PURETECH HEALTH PLC
09/20 PURETECH HEALTH : Notes US Patent Issuance Broadly Covering Methods of Assessing..
09/20 PURETECH HEALTH : Notes U.S. Patent Issuance Broadly Covering Methods of Assessi..
09/07 PURETECH HEALTH : Exclusively Licenses Glyph Technology from Monash University t..
08/29 PURETECH HEALTH : Exclusively Licenses Glyph Technology from Monash University t..
08/25PURETECH HEALTH PLC : half-yearly earnings release
08/15 PURETECH HEALTH : Notice of Half-Yearly Results
07/13 PURETECH HEALTH : Presents Data Supporting Treatment Approach for Interstitial C..
07/12 PURETECH HEALTH : Gelesis Announces Last Patient Visit in the Pivotal Gelesis100..
07/12 PURETECH HEALTH : Gelesis Announces Last Patient Out in the Pivotal Gelesis100 W..
06/28 PURETECH HEALTH : Akili Appoints Former Cubist CEO, Rob Perez, as Executive Chai..
More news
Sector news : Biotechnology & Medical Research - NEC
09/20DJSANOFI : Alnylam Report Positive Patisiran Phase III Trial, First-Ever for RNAi ..
09/15 Drug industry on tenterhooks as Maryland price-gouging law nears
09/07 New AstraZeneca, Amgen drug looks strong rival in severe asthma
08/30DJFDA Approves Pioneering Cancer Treatment With $475,000 Price Tag -- Update
08/30DJFDA Approves Pioneering Cancer Treatment With $475,000 Price Tag
08/29DJGILEAD SCIENCES : Bets $11 Billion On New Cancer Therapy -- WSJ
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
09/20PureTech Health Notes U.S. Patent Issuance Broadly Covering Methods of Assess.. 
09/20PureTech Health Notes U.S. Patent Issuance Broadly Covering Methods of Assess.. 
09/20PureTech Health Notes U.S. Patent Issuance Broadly Covering Methods of Assess.. 
09/19PureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology fo.. 
09/19PureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology fo..
1
More tweets
Qtime:13
Financials ($)
Sales 2017 1,63 M
EBIT 2017 -120 M
Net income 2017 -97,2 M
Finance 2017 3,37 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 264x
EV / Sales 2018 134x
Capitalization 432 M
Chart PURETECH HEALTH PLC
Duration : Period :
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 3,13 $
Spread / Average Target 70%
EPS Revisions
Managers
NameTitle
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Business & Strategy Officer
Joichi Ito Non-Executive Chairman
Stephen Muniz Chief Operations Officer, Secretary & Director
Eric Elenko Chief-Research & Strategy
Sector and Competitors
1st jan.Capitalization (M$)
PURETECH HEALTH PLC14.53%432
INCYTE CORPORATION14.56%24 235
QUINTILES IMS HOLDINGS INC24.44%20 267
LONZA GROUP57.01%19 853
CELLTRION, INC.--.--%15 738
ALNYLAM PHARMACEUTICALS, INC.204.06%10 359